Literature DB >> 8990126

Altered calcium homeostasis and ultrastructure in motoneurons of mice caused by passively transferred anti-motoneuronal IgG.

J I Engelhardt1, L Siklos, S H Appel.   

Abstract

Calcium homeostasis and ultrastructure are altered in motor axon terminals (AT) of amyotrophic lateral sclerosis (ALS) patients and in mice injected with ALS IgG and exhibit increased density of synaptic vesicles and increased intracellular calcium. To develop an immune-mediated passive transfer experimental model of both systemic weakness and altered morphology, mice were inoculated intraperitoneally with anti-motoneuronal IgG. Animals initially manifested muscle stiffness and evidence of autonomic cholinergic hyperactivity. Electron microscopic cytochemistry within 12 hours (h) demonstrated significantly increased density of synaptic vesicles and calcium both in axon terminals of neuromuscular junctions and synaptic boutons on spinal motoneurons. After 24 h the mice were severely weak and premorbid. The number of synaptic vesicles was still larger than normal, but calcium was depleted from axon terminals and synaptic boutons. The motoneuron perikarya demonstrated the dilatation of the Golgi system and the rough endoplasmic reticulum with an increased amount of calcium. The NMDA receptor antagonist, MK-801, and the L-type calcium channel antagonist, Diltiazem, prevented clinical symptoms and some morphological alterations. These data demonstrate that high titer anti-motoneuronal IgG can induce severe weakness and produce similar ultrastructural features of motor axon terminals in human ALS and in mice injected with ALS IgG, and support a key role for calcium in selective vulnerability of motoneurons.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8990126     DOI: 10.1097/00005072-199701000-00003

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  7 in total

1.  Expression of alpha 1D subunit mRNA is correlated with L-type Ca2+ channel activity in single neurons of hippocampal "zipper" slices.

Authors:  K C Chen; E M Blalock; O Thibault; P Kaminker; P W Landfield
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

2.  Calcium signaling pathways mediating synaptic potentiation triggered by amyotrophic lateral sclerosis IgG in motor nerve terminals.

Authors:  Mario R Pagani; Ricardo C Reisin; Osvaldo D Uchitel
Journal:  J Neurosci       Date:  2006-03-08       Impact factor: 6.167

3.  Talampanel reduces the level of motoneuronal calcium in transgenic mutant SOD1 mice only if applied presymptomatically.

Authors:  Melinda Paizs; Massimo Tortarolo; Caterina Bendotti; József I Engelhardt; László Siklós
Journal:  Amyotroph Lateral Scler       Date:  2011-05-30

4.  Calcium signaling in neurodegeneration.

Authors:  Philippe Marambaud; Ute Dreses-Werringloer; Valérie Vingtdeux
Journal:  Mol Neurodegener       Date:  2009-05-06       Impact factor: 14.195

5.  Intraperitoneally administered IgG from patients with amyotrophic lateral sclerosis or from an immune-mediated goat model increase the levels of TNF-α, IL-6, and IL-10 in the spinal cord and serum of mice.

Authors:  Izabella Obál; Gergely Klausz; Yvette Mándi; Mária Deli; László Siklós; József I Engelhardt
Journal:  J Neuroinflammation       Date:  2016-05-24       Impact factor: 8.322

6.  Immunoglobulins G from Sera of Amyotrophic Lateral Sclerosis Patients Induce Oxidative Stress and Upregulation of Antioxidative System in BV-2 Microglial Cell Line.

Authors:  Milena Milošević; Katarina Milićević; Iva Božić; Irena Lavrnja; Ivana Stevanović; Dunja Bijelić; Marija Dubaić; Irena Živković; Zorica Stević; Rashid Giniatullin; Pavle Andjus
Journal:  Front Immunol       Date:  2017-11-23       Impact factor: 7.561

7.  Passive Transfer of Sera from ALS Patients with Identified Mutations Evokes an Increased Synaptic Vesicle Number and Elevation of Calcium Levels in Motor Axon Terminals, Similar to Sera from Sporadic Patients.

Authors:  Valéria Meszlényi; Roland Patai; Tamás F Polgár; Bernát Nógrádi; Laura Körmöczy; Rebeka Kristóf; Krisztina Spisák; Kornélia Tripolszki; Márta Széll; Izabella Obál; József I Engelhardt; László Siklós
Journal:  Int J Mol Sci       Date:  2020-08-03       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.